Ali J. Satvat

Insider Reports History

Location
Menlo Park, CA
Signature
/s/ Ali J. Satvat
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ali J. Satvat:

Company Role Class Num Shares Value Price $ Report Date Ownership
BridgeBio Pharma, Inc. Director Common Stock 165,993 $5,784,856 $34.85 20 Jun 2025 Direct
Coherus Oncology, Inc. Director Stock Option (Right to Buy) 112,000 12 Jun 2025 Direct
BridgeBio Pharma, Inc. Director Stock Option (Right to Buy) 8,425 20 Jun 2025 Direct

Insider Reports Filed by Ali J. Satvat

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BBIO BridgeBio Pharma, Inc. 20 Jun 2025 2 $0 4 Director 24 Jun 2025, 19:06
CHRS Coherus Oncology, Inc. 12 Jun 2025 1 $0 4 Director 13 Jun 2025, 18:46
BBIO BridgeBio Pharma, Inc. 30 Dec 2024 6 +$2,585,134 4 Director 31 Dec 2024, 17:52
BBIO BridgeBio Pharma, Inc. 21 Jun 2024 1 $0 4 Director 25 Jun 2024, 17:40
BBIO BridgeBio Pharma, Inc. 21 Jun 2023 1 $0 4 Director 23 Jun 2023, 16:23
BBIO BridgeBio Pharma, Inc. 22 Jun 2022 1 $0 4 Director 24 Jun 2022, 16:34
BBIO BridgeBio Pharma, Inc. 17 Jun 2021 1 $0 4 Director 22 Jun 2021, 20:00